Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Free Thinking: Behavioural economics

    March 27, 2015 |  

    Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

    Books espousing behavioural economic theories, such as “Thinking Fast and Slow” authored by Daniel Kahneman, have become essential reading for market researchers looking to improve their understanding of how people think, feel and behave.

    This theory can be very useful in consumer research, where we already know the power brands have on influencing purchase decisions. But can behavioural economics theory be applied to the pharmaceutical healthcare industry, where treatment decisions are often made in a highly regulated environment and by educated professionals using sound, rational judgement?

    Download and read the complimentary whitepaper at http://bit.ly/1L5YhyM

    We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. 

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Webinar: Understanding Patient Willingness to Pay

    What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets?

    Research Partnership welcomes 22 new Graduates

    As part of our continued growth, we are delighted to announce a new intake of 17 Research Analysts and 5 Fieldwork Project Coordinators into our annual market research graduate programme.http://www.researchpartnership.com/news/2016/09/new-graduates-2016/

    Case study: Tracking a product launch in a dynamic and competitive market

    With the imminent expected approval and launch of a new product, our client needed to conduct global tracking research to understand knowledge, perceptions, awareness and recall around their product and the quality...

    Understanding the Chronic Disease Patient Journey in Emerging Markets

    The benefits of understanding the patient journey are well documented in mature markets. But in emerging markets the patient journey is less understood. We recently presented a webinar hosted by...

    Latest wave of Therapy Watch IBD to run this month

    The IBD syndicated market tracker is part of our large auto-immune portfolio

    Research Partnership launches new patient report – Living with Lupus (SLE)

    Living with Lupus (SLE) is a quantitative study conducted online amongst patients in the US and European markets. The report will consist of 30-minute face to face interviews with a...

    Webinar: Ensuring an Actionable Segmentation

    A segmentation study comes with high visibility and high stakes across your marketing and sales organisations. Ensuring that a segmentation is actionable is a consistent issue, particularly when stakeholders with multiple...

    Interactive infographic: LATAM

    An overview of the six most-commonly researched, largest pharma markets in Latin America

    Immuno-oncology: The market opportunity for PD-1/PD-L1s

    Immuno-oncology is the new frontier in cancer treatment. Using the body’s own immune system to treat cancer, new therapies are producing impressive survival benefits, with reduced side effects. Of these therapies,...

    Case Study: Using ‘Journey to the Future’ projective techniques to understand evolving customer expectations

    Our client was developing a portfolio of innovative treatments and was in the process of recruiting a sales force to support the promotion of this portfolio. Research was required to...